CEACAM5 and colorectal carcinoma: Additionally, Guet al. [118] identified a potential early diagnostic biomarker comprising four glycosylation patterns and CEA for the simultaneous discrimination of advanced adenoma (AUC=0.847) and CRC (AUC=0.844) patients from healthy controls.